Konstantinos trained as a computational neuroscientist, worked in corporate business development and at a biotechnology venture fund before starting Nevro Corp (NYSE:NVRO). A surgically placed brain targeting interface, using electrical signals to enable return to normal function, is the core technology his team developed at Nevro. As the Founder and CEO, Konstantinos, led product design, clinical development and introduced the first product (an FDA approved chronic pain therapy) to market.
Currently, Dr. Alataris is leading the development of personalized therapies using noninvasive brain interfaces. With his core team from Nevro and the support of leading academic researchers, he co-founded Vorso Corp, a venture backed start up. The company is currently in the clinical development phase for multiple indications.
Konstantinos, has also worked in drug device combination products (immediate acting neurology products), neurosurgery and wearable diagnostics.
Dr. Alataris received Master’s degrees in Electrical Engineering and Business and a Ph.D. in Biomedical Engineering with focus in Computational Neuroscience from the University of Southern California. He received a Bachelor of Science in Electrical and Computer Engineering from the National Technical University of Athens, Greece.
Douglas Weber, Ph.D.
Doug Weber is an Associate Professor of Bioengineering at the University of Pittsburgh and his research is focused on creating neurotechnologies that repair, replace, and enhance sensory, motor, autonomic, and cognitive functions. He completed a 4-year term (2013-2017) as a Program Manager at the Defense Advanced Research Projects Agency (DARPA), where he was a founding member of the Biological Technologies Office. During his tenure at DARPA, he created and managed a $300M US portfolio of neurotechnology programs, including the HAPTIX, ElectRx, and TNT programs. Dr. Weber received a B.S. in Biomedical Engineering from the Milwaukee School of Engineering in 1994 and M.S. and Ph.D. degrees in Bioengineering from Arizona State University in 2000 and 2001.
Insoo Suh, M.D.
Dr. Insoo Suh is an endocrine surgeon specializing in diseases of the thyroid, parathyroid, adrenal, and pancreas. His clinical interests include the application of minimally-invasive techniques, such as laparoscopy and robotics, to endocrine surgery. He is professor in the UCSF Department of Surgery. Suh received a B.S. in Molecular Biophysics and Biochemistry from Yale University, and obtained his M.D. from UCSF. Suh has received several awards in recognition of his clinical and research achievements, including the Fred H. and Esther E. Nusz Achievement Award and the LoGerfo Basic Science Research Award from the American Association of Endocrine Surgeons. He is active in several national organizations, including the American College of Surgeons and the American Association of Endocrine Surgeons. Suh has authored more than 50 peer-reviewed publications. He is also a co-founder of Prescient Surgical, Inc., a commercial-stage surgical device startup focused on the prevention of surgical site infection.